Advertisement

Topics

Quidel’s Sofia® 2 Point-of-Care Immunoassay Analyzer Receives Multiple Awards from Good Design Australia®’s 2017 Good Design Awards®

18:45 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that its Sofia 2 point-of-care immunoassay analyzer has receiv...

Other Sources for this Article

Quidel Corporation
Randy Steward
Chief Financial Officer
(858) 552-7931
or
Media and Investors Contact:
Ruben Argueta
(858) 646-8023
rargueta@quidel.com

NEXT ARTICLE

More From BioPortfolio on "Quidel’s Sofia® 2 Point-of-Care Immunoassay Analyzer Receives Multiple Awards from Good Design Australia®’s 2017 Good Design Awards®"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...